In this issue:
Sarcoidosis in Switzerland: environmental factors
Morbidity/mortality associated with restrictive spirometry patterns
Cost effectiveness of screening with HRCT for LAM
Clinical predictors of an IPF diagnosis
Sildenafil for advanced IPF
Pirfenidone in IPF
Imatinib for IPF
Cryptogenic fibrosing alveolitis and lung cancer
Survival after bilateral vs. single lung transplants for IPF
Pulmonary rehabilitation in RLDs
Please login below to download this issue (PDF)